TCR Engineering High Impact Factor Journals

Therapy with TCR-engineered T cells is highly potent but reactivity outside tumor needs to be minimized whereas T cell trafficking inside tumor needs to be maximized.

 

T cell target antigens need to show absent expression in a multitude of healthy tissues, including all vital organs.

 

Recognition motif (derived from cognate peptide) of therapeutic TCR needs to be absent from endogenous proteins.

 

Defects in intra-tumoral accumulation of CD8 T cells are categorized according to entry, migration, and local activation of T cells.

Conference Proceedings

Relevant Topics in Health Care & Nursing

Awards Nomination 17+ Million Readerbase
Google Scholar citation report
Citations : 12308

Health Science Journal received 12308 citations as per Google Scholar report

Abstracted/Indexed in
  • Google Scholar
  • Genamics JournalSeek
  • China National Knowledge Infrastructure (CNKI)
  • CiteFactor
  • CINAHL Complete
  • Scimago
  • Electronic Journals Library
  • Directory of Research Journal Indexing (DRJI)
  • EMCare
  • WorldCat
  • University Grants Commission
  • Geneva Foundation for Medical Education and Research
  • Secret Search Engine Labs
  • Euro Pub

View More »